215 related articles for article (PubMed ID: 17097559)
1. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia.
Deshpande AJ; Cusan M; Rawat VP; Reuter H; Krause A; Pott C; Quintanilla-Martinez L; Kakadia P; Kuchenbauer F; Ahmed F; Delabesse E; Hahn M; Lichter P; Kneba M; Hiddemann W; Macintyre E; Mecucci C; Ludwig WD; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
Cancer Cell; 2006 Nov; 10(5):363-74. PubMed ID: 17097559
[TBL] [Abstract][Full Text] [Related]
2. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros.
Greif PA; Tizazu B; Krause A; Kremmer E; Bohlander SK
Oncogene; 2008 May; 27(20):2886-96. PubMed ID: 18037964
[TBL] [Abstract][Full Text] [Related]
3. Clathrin assembly lymphoid myeloid leukemia-AF10-positive acute leukemias: a report of 2 cases with a review of the literature.
Huh JY; Chung S; Oh D; Kang MS; Eom HS; Cho EH; Han MH; Kong SY
Korean J Lab Med; 2010 Apr; 30(2):117-21. PubMed ID: 20445327
[TBL] [Abstract][Full Text] [Related]
4. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice.
Deshpande AJ; Rouhi A; Lin Y; Stadler C; Greif PA; Arseni N; Opatz S; Quintanilla-Fend L; Holzmann K; Hiddemann W; Döhner K; Döhner H; Xu G; Armstrong SA; Bohlander SK; Buske C
Leukemia; 2011 Nov; 25(11):1718-27. PubMed ID: 21681188
[TBL] [Abstract][Full Text] [Related]
5. CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12.
Mulaw MA; Krause A; Deshpande AJ; Krause LF; Rouhi A; La Starza R; Borkhardt A; Buske C; Mecucci C; Ludwig WD; Lottaz C; Bohlander SK
Leukemia; 2012 May; 26(5):1012-9. PubMed ID: 22064352
[TBL] [Abstract][Full Text] [Related]
6. Modeling the initiation and progression of human acute leukemia in mice.
Barabé F; Kennedy JA; Hope KJ; Dick JE
Science; 2007 Apr; 316(5824):600-4. PubMed ID: 17463288
[TBL] [Abstract][Full Text] [Related]
7. Searching for leukemia stem cells--not yet the end of the road?
Jordan CT
Cancer Cell; 2006 Oct; 10(4):253-4. PubMed ID: 17045202
[TBL] [Abstract][Full Text] [Related]
8. The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
Dutta S; Krause A; Vosberg S; Herold T; Ksienzyk B; Quintanilla-Martinez L; Tizazu B; Chopra M; Graf A; Krebs S; Blum H; Greif PA; Vetter A; Metzeler K; Rothenberg-Thurley M; Schneider MR; Dahlhoff M; Spiekermann K; Zimber-Strobl U; Wolf E; Bohlander SK
Leukemia; 2016 May; 30(5):1166-76. PubMed ID: 26686248
[TBL] [Abstract][Full Text] [Related]
9. Hypothesis: myeloid-restricted hematopoietic stem cells with self-renewal capacity may be the transformation site in acute myeloid leukemia.
Satoh C; Ogata K
Leuk Res; 2006 Apr; 30(4):491-5. PubMed ID: 16183117
[TBL] [Abstract][Full Text] [Related]
10. Lymphoid progenitors as candidate cancer stem cells in AML: new perspectives.
Deshpande AJ; Buske C
Cell Cycle; 2007 Mar; 6(5):543-5. PubMed ID: 17329976
[TBL] [Abstract][Full Text] [Related]
11. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
Muntean AG; Hess JL
Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute myeloid leukemia by directly targeting both leukemia stem cells and oncogenic molecule with specific scFv-immunolipoplexes as a deliverer.
Wang GP; Qi ZH; Chen FP
Med Hypotheses; 2008; 70(1):122-7. PubMed ID: 17566667
[TBL] [Abstract][Full Text] [Related]
13. Positive selection for CD90 as a purging option in acute myeloid leukemia stem cell transplants.
Feller N; Kelder A; Westra G; Ossenkoppele GJ; Schuurhuis GJ
Cytometry B Clin Cytom; 2008 Jan; 74(1):9-16. PubMed ID: 18061946
[TBL] [Abstract][Full Text] [Related]
14. CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice.
Lange AP; Almeida LY; Araújo Silva CL; Scheucher PS; Chahud F; Krause A; Bohlander SK; Rego EM
Braz J Med Biol Res; 2019; 52(6):e8424. PubMed ID: 31141090
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
[TBL] [Abstract][Full Text] [Related]
16. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
18. Transformation from committed progenitor to leukemia stem cells.
Krivtsov AV; Feng Z; Armstrong SA
Ann N Y Acad Sci; 2009 Sep; 1176():144-9. PubMed ID: 19796242
[TBL] [Abstract][Full Text] [Related]
19. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10.
Archangelo LF; Gläsner J; Krause A; Bohlander SK
Oncogene; 2006 Jul; 25(29):4099-109. PubMed ID: 16491119
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cells are not the direct target of spontaneous leukemic transformation in p18(INK4C)-null reconstituted mice.
Yuan Y; Yu H; Boyer MJ; Song X; Cao S; Shen H; Cheng T
Cancer Res; 2006 Jan; 66(1):343-51. PubMed ID: 16397248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
